Ramosetron versus Ondansetron in the Prevention of Chemotherapy-Induced Gastrointestinal Side Effects: A Prospective Randomized Controlled Study

Publisher： Karger

E-ISSN： 1421-9794|53|1|44-50

ISSN： 0009-3157

Source： Chemotherapy, Vol.53, Iss.1, 2007-01, pp. : 44-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Double-Blind, Crossover, Randomized Comparison of Granisetron and Ramosetron for the Prevention of Acute and Delayed Cisplatin-Induced Emesis in Patients with Gastrointestinal Cancer: Is Patient Preference a Better Primary Endpoint?

By  

Chemotherapy, Vol. 49, Iss. 6, 2003-12 ,pp. : 316-323

Karger

Access to resources Recommend Favorite

Optimal Dose Period for Indisetron Tablets for Preventing Chemotherapy-Induced Nausea and Vomiting with Modified FOLFOX6: A Randomized Pilot Study

By  

Chemotherapy, Vol. 58, Iss. 6, 2013-01 ,pp. : 439-444

Karger

Access to resources Recommend Favorite

Prevention of Chemotherapy-Induced Neutropenia with Pegfilgrastim: Pharmacokinetics and Patient Outcomes

By  

Chemotherapy, Vol. 58, Iss. 5, 2012-12 ,pp. : 387-398

Karger

Access to resources Recommend Favorite

Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy

By Lee Gihyun   Kim Sun Kwang  

Molecules, Vol. 21, Iss. 9, 2016-09 ,pp. : 1252-1252

MDPI

Access to resources Recommend Favorite

Chemotherapy‐Induced Diarrhoea

By  

The Australian Journal of Hospital Pharmacy, Vol. 30, Iss. 5, 2000-10 ,pp. : 229-230

John Wiley & Sons Inc

Access to resources Recommend Favorite